Thymosin Alpha-1 is a biologically active peptide derived from prothymosin-alpha. Current hypotheses consider Thymosin Alpha-1 to be the main constituent of Thymosin Fraction-5, and as such it is considered to be the active component that restores the immune function in both athymic animals and animals with dysfunctional thymus glands. [Thymosin Alpha-1](https://en.wikipedia.org/wiki/Thymosin_%CE%B11 "thymosin alpha 1") was among the first peptide isolates of Thymosin Fraction-5 to be sequenced
Immune Function
Thymosin Alpha-1
“Importantly, **Ta1 acts without overstimulation of cytokine production** and is generally well tolerated; it has an excellent safety profile and does not appear to induce the side effects and toxicities commonly associated with agents in this class such as interferon alpha and interleukin-2.” (1) “Clinical trials using Ta1 in the treatment of patients with immunodeficiency or cancer indicate that this agent is nontoxic, enhances immune
Immune Function
Thymosin Alpha-1
## What is Thymosin Alpha-1? Thymosin alpha-1 is peptide containing 28 amino acid residues that are N-terminally acetylated and proteolytically processed from prothymosin alpha. Thymosin alpha-1 was isolated by Goldstein and coworkers from thymosin fraction 5, a mixture of peptides from calf thymus in the 1970s. It is used to improve immune responses in times of need.
Immune Function
Thymosin Alpha-1
Thymosin Alpha-1 is a major component of Thymosin Fraction 5 found in the thymus. The thymus is responsible for regulating the immune system. Thymosin Alpha-1 is prescribed to optimize the performance of your immune health and improve general wellness by preventing infections such as the common cold or the flu. It acts to augment T-cell function; T-cells are a part of the adaptive immune system which fights off infection.
Immune Function
Thymosin Alpha-1
Arthritis is a chronic condition that affects millions of people worldwide, and it can cause severe pain, inflammation, and stiffness in the joints. While there are various treatments available to manage arthritis symptoms, many of them have limitations and may not be effective for everyone. This has led researchers to explore new therapeutic options that could potentially provide better relief and improve the quality of life for those living with arthritis. Among these options are ARA 290, t
AOD-9604
ARA-290
Thymosin Alpha-1